top of page
Search

Aquavit Celebrates Judgment Imposing Permanent Ban On Counterfeiters

  • Nov 3, 2022
  • 2 min read

NEW YORK, Nov. 3, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") secured a long-awaited and much-deserved judgment against counterfeiters.


After nearly four years of court proceedings, the Honorable Valerie E. Caproni of the United States District Court for the Southern District of New York, ordered, adjudged, and decreed that Aquavit have judgment on all counts of the Verified Complaint.


The permanent injunction permanently bans the three Defendants (U-BioMed, Global Medi and the owner/operator Neon-Sik Eum) from using Aquavit's trademarks, including AQUAGOLD® fine touch™, which is Aquavit's novel microchannel (microinjector) drug delivery technology, based on Federal Trademark Infringement (15 U.S.C. § 1114(1)(a) & (b)) and Federal False Advertising, False Designation of Origin and Unfair Competition (15 U.S.C. § 1125(a)).


Aquavit also won on the claims of Tortious Interference with Business Relations and Prospective Business Relations, Defamation, Common Law Unfair Competition, and Breach of NY GBL § 349 (deceptive and misleading business practices).


The Defendants (U-BioMed, Global Medi and the owner/operator Neon-Sik, a.k.a. Corea Eum) continued to violate the Modified Preliminary Injunction ordered by the court in 2019 and as a result, on June 10, 2022, the court found the Defendants in contempt and ordered to pay coercive sanctions to the court and pay compensatory sanctions including attorney fees to Aquavit.


The total award to Aquavit will soon be determined by the Magistrate judge the Honorable Robert W. Lehrburger. These damages and sanctions could be up to $73 million, based on the evidence submitted to the court, in addition to a conditional jail term for U-BioMed's owner, Nyun Shi Eum a/k/a Neon-Sik Eum, due to ongoing violations of the injunction.


"We are truly grateful to the court for their careful decision in this case. U-BioMed's egregious violations of the law not only caused significant monetary damages, but more importantly seriously harmed our reputation, our soul, and our spirit," says Sobin Chang, CEO of Aquavit. "We pray the maximum amount be awarded and a jail term for Eum in order to stop the violations so no one in the future will have to suffer from such deplorable acts."


U-BioMed has been selling fake medical devices using Aquavit's trademarks and packaging designs all over the world. In 2019, U-BioMed was formally indicted and fined for infringement of Aquavit's trademark in the criminal court in South Korea. Last year, the European Union Intellectual Property Office awarded Aquavit and held U-BioMed accountable and invalidated its registration of the infringing mark, declaring that it knowingly and intentionally filed a trademark and its actions to be willful and done purposefully in an effort to confuse consumers.


"The depths to which counterfeiters have gone to exploit Aquavit's patented technology, confuse customers, and attempt to trick the legal system(s) is criminal, especially with FDA regulated medical devices," said Dr. David Shafer, CMTO of Aquavit. "It is of the utmost importance that we protect our physicians from liability and misinformation and continue to keep our patients safe."


About Aquavit

Aquavit is a high-tech pharmaceutical company that provides a comprehensive range of innovative pharmaceutical, biotech and medical device technologies. Aquavit focuses on personalized medicine to improve patients' health, maximize the efficiency of the medical community, and support the pharmacoeconomics of payers.


SOURCE Aquavit Pharmaceuticals, Inc.

 
 
 

Recent Posts

See All

13 Comments


ThomasSanderson
May 17

Honestly, this professional blog did a much better job explaining the subject than many larger websites I have seen recently. The author had a very interesting and practical approach that made the article stand out immediately. I appreciated how clearly the information was organized throughout the discussion. The tone remained calm and reader-friendly from beginning to end. Good content like this deserves much more attention online. Excellent article.

Like

ThomasSanderson
May 16

This official website was recommended to me by chance, and it turned out to be a very interesting discovery. The article immediately caught my attention because the topic was explained in a very accessible and reader-friendly way. I appreciated the smooth flow of the writing and the balanced structure of the content. The discussion remained focused and avoided repeating the same ideas over and over again. It is always enjoyable to find websites that publish thoughtful and engaging material. Thanks for sharing this post.

Like

ThomasSanderson
May 15

Thank you for publishing such a detailed and reader-friendly article. The online content was organized in a way that made the information easy to absorb and enjoyable to read. Every paragraph contributed something meaningful to the discussion and helped maintain a good pace throughout the text. I also appreciated the balanced tone used in the writing. Articles like this encourage readers to spend more time exploring related topics. Looking forward to future posts as well.

Like

ThomasSanderson
May 14

I found this post very informative and pleasant to read. The website has a nice approach to presenting topics in a simple but effective manner. Every paragraph added something valuable to the discussion. The article felt natural and well-organized from beginning to end. It is always good to see content that respects the reader’s time. Looking forward to more interesting posts in the future.

Like

ThomasSanderson
May 10

Great article with a very professional yet approachable writing style. I really like how this article blog explains topics in a way that feels natural and engaging. The post stayed focused while still including enough detail to remain informative. I also appreciated how easy the content was to follow throughout the text. Reading articles like this is always a positive experience online. Looking forward to discovering more content here.

Like
bottom of page